Julio Rosenstock, director of the Dallas Diabetes Research Center, expanded on the results of tirzepatide, explaining that the SURPASS-3 trial showed that it leads to greater time in range
I am very happy with the progress and the shots
For patients who feel their progress has stalled, understanding the semaglutide plateau phenomenon and investigating reasons for not losing weight on semaglutide can reveal adjustable factors
Mounjaros FDA approval was for diabetes only, and Zepbound came to market later with approval for weight loss
Once-a-week shots are less often and are also not a cause of concern in the morning, but some still find it a bit scary to take a shot
When to Seek Medical Help Recognizing Emergency Symptoms If dizziness and blurred vision occur suddenly and are accompanied by other symptoms such as weakness, difficulty speaking, severe headache, chest pain, palpitations or loss of consciousness, seek emergency medical care immediately